LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

Search

Zoetis Inc

Abierto

SectorSanidad

80.57 5.29

Resumen

Variación precio

24h

Actual

Mínimo

76.36

Máximo

81.52

Métricas clave

By Trading Economics

Ingresos

-2M

601M

Ventas

-125M

2.3B

P/B

Media del Sector

12.715

49.888

BPA

1.42

Rentabilidad por dividendo

2.61

Margen de beneficios

26.569

Empleados

14,500

EBITDA

-6M

941M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+59.25% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

2.61%

2.38%

Próximas Ganancias

4 ago 2026

Fecha Próximo Dividendo

1 sept 2026

Próxima Fecha de Ex Dividendo

20 jul 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-15B

33B

Apertura anterior

75.28

Cierre anterior

80.57

Noticias sobre sentimiento de mercado

By Acuity

52%

48%

259 / 344 Clasificación en Healthcare

Zoetis Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

5 ago 2025, 11:06 UTC

Ganancias

Zoetis Sees 2025 Adj EPS $6.30-Adj EPS $6.40 >ZTS

5 ago 2025, 11:06 UTC

Ganancias

Zoetis Sees 2025 Rev $9.45B-$9.6B >ZTS

5 ago 2025, 11:05 UTC

Ganancias

Zoetis 2Q Adj EPS $1.76 >ZTS

Comparación entre iguales

Cambio de precio

Zoetis Inc previsión

Precio Objetivo

By TipRanks

59.25% repunte

Estimación a 12 Meses

Media 123.56 USD  59.25%

Máximo 150 USD

Mínimo 95 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Zoetis Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

12 ratings

6

Comprar

6

Mantener

0

Vender

Sentimiento

By Acuity

259 / 344 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat